Medical/Pharmaceuticals
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
HANGZHOU, China, SHANGHAI and BOSTON, July 9, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that the first patient was successfully dosed on June 30 in...
2026-07-09 08:00
2349
MEDIPOST Inc. Treats First U.S. Participant in Phase III Trial of Umbilical Cord Stem Cell Therapy for Symptomatic Cartilage Defects Due to Knee Osteoarthritis
U.S. Phase III Trial Expands Clinical Investigation of Stem Cell Therapy for Knee Cartilage Defects CAMBRIDGE, Mass., July 8, 2026 /PRNewswire/ -- MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative d...
2026-07-08 10:43
2550
Wegovy® (semaglutide) label updated in Singapore with higher dose supported by STEP UP evidence
* Up to one in three participants on semaglutide 7.2 mg achieved at least 25% weight loss over 72 weeks * Mean weight loss with semaglutide 7.2 mg reached 21%, reflecting overall treatment efficacy * Up to 84% of weight loss was driven by reductions in fat mass, supporting meaningful improv...
2026-07-08 09:22
2181
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
EAST RUTHERFORD, N.J., July 7, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), proudly announces that Snapdragon Chemistry, a Cambrex company, together with NewAmsterdam Pharma, has received the American Chemical Society's 2026 Green Chem...
2026-07-07 20:00
2347
HKSH's First-in-Asia Comparative Study on Radiotherapy for Breast Cancer Reveals Hypofractionated Proton Therapy Prevents Breast Cancer Recurrence with 100% Survival Rate
Minimises Cardiopulmonary Concerns and Maintains Quality of Life HONG KONG, July 7, 2026 /PRNewswire/ -- The HKSH Cancer Centre under HKSH Medical Group (HKSH) introduced proton therapy in 2023, covering a wide range of cancer types including breast, prostate as well as head and neck cancers, an...
2026-07-07 19:27
2471
Healome Therapeutics Closes £2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases
BIRMINGHAM, England, July 7, 2026 /PRNewswire/ -- Healome Therapeutics ("Healome"), a University of Birmingham spinout developing a proprietary eye-drop matrix technology for ocular surface diseases, has closed a GBP£2 million oversubscribed seed financing round led by Empirical Ventures, with p...
2026-07-07 19:07
1979
Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib
SHANGHAI, July 7, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the closing of its previously announc...
2026-07-07 18:53
2284
ESHRE 42nd Annual Meeting: Halving fertility treatment costs could more than double births, major global study shows
A landmark international study has found that halving patient out-of-pocket costs was associated with a 2.67-fold increase in births achieved through assisted reproductive technology (ART). LONDON, July 7, 2026 /PRNewswire/ -- Presented at the 42nd Annual Meeting of the European Society of Human...
2026-07-07 07:01
2230
Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
A blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and highlighted by the American Society of Clinical Oncology. For Gene Solutions, this milestone under...
2026-07-07 06:00
3100
Smarter, Lighter, & Construction-Free: Egg Medical Debuts EggNest® Complete 2.0 for Interventional Labs
MINNEAPOLIS, July 6, 2026 /PRNewswire/ -- Egg Medical
2026-07-06 22:12
2890
TMRW Vault® Receives CE Mark Under the European Medical Device Regulation (MDR)
WILMINGTON, Del., July 6, 2026 /PRNewswire/ -- Reprotech today announced that
the TMRW Vault® has received CE marking as a Class IIa medical device under
Regulation (EU) 2017/745, supporting commercialization in the European Union
and other international markets that recognize the CE mark.
2026-07-06 21:02
2401
Dx&Vx (DXVX) Partners with Over 40 Global Companies at BIO USA, "Focused Discussions on Overseas Out-Licensing Deals"
* Oral obesity drug with world-first mechanism of action unveiled, drawing strong on-site interest * Following successful Phase 1 clinical results, global discussions on OVM-200 expand * Meetings with over 40 companies, including major pharmaceutical companies, out-licensing now within reac...
2026-07-06 20:30
4230
World's First International Patient Begins Treatment with Newly Approved Solid Tumor CAR-T Therapy at Jiahui International Cancer Center
SHANGHAI, July 6, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) has welcomed the world's first international patient to begin treatment with Satri-cel, the world's first approved CAR-T therapy for a solid tumor, marking a historic milestone in expanding global access to China's l...
2026-07-06 17:15
2405
Ascletis Submits Two IND Applications to U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formulation of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35
- ASC36_35 FDC, a once-monthly subcutaneous (SQ) injection co-formulation of ASC36 and ASC35, is a potentially first-in-class drug candidate targeting three validated targets of amylin receptor, GLP-1R and GIPR. - ASC36_35 FDC demonstrated approximately 51% greater relative body weight reducti...
2026-07-06 08:10
3289
Straits Forum | Taiwanese Youth Tells: Six Years Rooted in the Mainland - From Starting a Business to Ringing the Bell at HKEX
XIAMEN, China, July 3, 2026 /PRNewswire/ -- This is a news report by Hong
Kong Ta Kung Wen Wei Media Group Limited:
2026-07-04 16:29
6875
DoH and MIT- Koch Institute Partner to Advance AI-Driven Cancer Research
ABU DHABI, UAE, July 3, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and the MIT – Koch Institute for Integrative Cancer Research have announced a strategic collaboration to advance AI-enabled oncology research, translatio...
2026-07-03 18:28
4915
Evangel Hospital Launches "3 Instruments of Peace" Service in Support of Advance Medical Directives Implementation
HONG KONG, July 3, 2026 /PRNewswire/ -- The Advance Medical Directives (AMD) legislation will come into effect on 31 July 2026, allowing adults with mental capacity to express their preferences in advance regarding end-of-life care and life-sustaining treatments. Evangel Hospital welcomes this de...
2026-07-03 16:54
7746
Shanghai SinoUnited Hospital Announced Availability of World's First CAR-T Therapy for Solid Tumors in Advanced Gastric Cancer
SHANGHAI, July 3, 2026 /PRNewswire/ -- Shanghai SinoUnited Hospital today announced the availability of satricabtagene autoleucel ("satri-cel"), the world's first chimeric antigen receptor (CAR) T-cell therapy approved for the treatment of solid tumors, for eligible patients with Claudin18.2-posi...
2026-07-03 13:36
4560
Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
* End-of-treatment data from ENRICH demonstrated higher HBsAg loss rates, consistent with ENSURE Cohort 4, confirming the role of BRII-179 in priming immune responses for functional cure strategies * End-of-treatment data from ENHANCE did not demonstrate improved HBsAg loss rates compared to ...
2026-07-03 08:00
3990
Fosun International Garners Five Awards from Corporate Governance Asia
Chen Qiyu and Xu Xiaoliang, Co-CEOs of Fosun International win Asia's Best CEO fromCorporate Governance Asia Fosun International receives Sustainable Asia Award 2026, Best Environmental Responsibility Award and Best Corporate Communications Award HONG KONG, July 2, 2026 /PRNewswire/ -- On 30 Jun...
2026-07-02 12:43
6753
Week's Top Stories
Most Reposted
InfoComm Asia 2026 - Asia's Super Connector for Professional AV - Takes Place Next Week in Bangkok
[Picked up by 297 media titles]
2026-07-07 09:00
PropertyGuru Group's 2025 Sustainability Report Reinforces its Commitment to More Resilient and Inclusive Urban Futures Across Southeast Asia
[Picked up by 291 media titles]
2026-07-08 12:09
A New Chapter Beckons: Four Seasons Resorts of Asia Celebrates Parenthood with Babymoon Offerings
[Picked up by 291 media titles]
2026-07-10 13:30
NCS launches enterprise AI platforms and products; deepens partnerships to accelerate AI-driven business transformation
[Picked up by 286 media titles]
2026-07-09 08:00Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
[Picked up by 285 media titles]
2026-07-07 06:00
Most Read
Founder Olive Tai Appointed Chairman of the Board of Synagistics; John Wu Appointed Chief Executive Officer as Company Enters Next Stage of AI and Digital Commerce Growth
2026-07-06 20:23
7854
Anime "Kagurabachi" Takes Anime Expo by Storm!~ Taihi Kimura; "I'm so happy to absorb everyone's passion!" Moved by the World Premiere!
2026-07-05 02:27
6801
